Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 244 of 5804
-
Centenarians put to the test: can exercise reverse frailty at age 100?
Symptom relief OngoingThis study aims to evaluate the effects of a home intervention of individualized multicomponent physical exercise program (including strength, balance, flexibility, and mobility training) on functional health, physical capacity, and biological markers in centenarians. The interve…
Phase: NA • Sponsor: Fundacion Miguel Servet • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Blood thinner duration trial aims to save limbs in severe artery disease
Disease control Recruiting nowChronic limb threatening ischemia (CLTI) is defined as ischemic foot pain at rest or non-healing foot wounds that is attributable to severe peripheral arterial disease (PAD).Revascularization is the cornerstone of therapy to relieve ischemic pain, prevent limb loss and preserve p…
Phase: PHASE3 • Sponsor: Fondation Hôpital Saint-Joseph • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New heart zapping device could free patients from irregular heartbeat
Disease control Recruiting nowThe goal of this clinical trial is to learn if the FARAFLEX™ Mapping and pulsed field ablation (PFA) System can safely and effectively treat symptomatic, drug-refractory Paroxysmal atrial fibrillation (PAF) and Persistent atrial fibrillation (PersAF). The main question it aims to…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a blood filter sweep out hidden plastic pollution?
Knowledge-focused ENROLLING_BY_INVITATIONThis prospective, non-interventional, within-subject paired biomarker study will evaluate whether circulating microplastic and nanoplastic-associated particle concentrations and PFAS concentrations in peripheral blood change after clinically prescribed double-filtration plasmaphe…
Sponsor: Proxima Health, Inc. • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
New oral drug takes on tough brain cancer in phase 3 trial
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate efficacy and safety of tirabrutinib alone compared with rituximab and temozolomide (R-TMZ) combination therapy in participants with Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL).
Phase: PHASE3 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug duo aims to rescue PNH patients failing standard care
Disease control Recruiting nowThis study is researching a treatment combination with two experimental drugs called pozelimab and cemdisiran referred to as "study drugs". Researchers are looking for a better way to treat Paroxysmal Nocturnal Hemoglobinuria (PNH). The aim of the study is to see how well the po…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Leukemia shot could replace long IV drips
Disease control Not yet recruitingThe main objective of this trial is to demonstrate that subcutaneous (SC) blinatumomab in conjunction with chemotherapy (Arm B) is non-inferior to continuous intravenous infusion (cIV) blinatumomab in conjunction with chemotherapy (Arm A) in overall survival (OS) in newly diagnos…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Could skipping a common antibiotic be just as safe for heart infections?
Disease control Recruiting nowThe primary objective of this study is to demonstrate that a rifampin-free regimen is non-inferior to the rifampin-containing regimen in terms of all-cause mortality in staphylococcal prosthetic valve endocarditis within 6 months after randomization.
Phase: PHASE3 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug duo targets advanced gynecologic cancers in early trial
Disease control Recruiting nowThis is a prospective, multicenter, single-arm clinical trial investigating Becotatug Vedotin in combination with Zimberelimab for the treatment of patients with recurrent and metastatic cervical cancer, vulvar cancer, and vaginal cancer. A total of 30 patients are expected to be…
Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug duo aims to stop rare heart disease in its tracks
Disease control OngoingThe purpose of this randomised, double-blind, placebo-controlled, multicenter study is to evaluate the efficacy and safety of concomitant use of eplontersen and ALXN2220 compared with eplontersen and placebo in adult participants with Transthyretin-mediated amyloid cardiomyopathy…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New hope for lung scarring: AZD8965 enters Mid-Stage trial
Disease control Recruiting nowThis Phase IIb study aims to evaluate the efficacy, safety, and tolerability of 3 doses of AZD8965 treatment compared to placebo in participants with IPF, including those on antifibrotic therapy (nintedanib, pirfenidone, nerandomilast), either alone or in combination, or in those…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Pee test could spot colon cancer early in africa
Diagnosis Recruiting nowThe purpose of this study is to find out whether a urine test can detect colorectal cancer (CRC) and precancerous polyps in participants living in Ghana, Tanzania, and South Africa.
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Antioxidant supplement may boost IVF outcomes for older women
Disease control Recruiting nowFemale fertility declines with advancing age, largely because of deteriorating oocyte quality driven by mitochondrial dysfunction and oxidative stress within the ovarian microenvironment. Alpha-lipoic acid (ALA) is a potent antioxidant that crosses cell and mitochondrial membrane…
Phase: NA • Sponsor: Kaohsiung Veterans General Hospital. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could a sprinkle of antibiotic powder in the ER prevent bone infections?
Disease control Not yet recruitingTo evaluate the feasibility, safety, and potential efficacy of applying vancomycin powder locally to open fractures in the emergency department prior to definitive surgical intervention.
Phase: PHASE3 • Sponsor: Atlantic Health System • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug delivery methods tested for tough breast cancer
Disease control Not yet recruitingAn Exploratory Study on the Efficacy and Safety of Different Administration Routes of SHR-A1811 in the Treatment of HER2-Positive Advanced Breast Cancer
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug aims to shield autoimmune patients from Life-Threatening infections
Disease control Recruiting nowA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Panzyga for Prevention of Major Infection in Patients with Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions Receiving Treatment with B-cell Depletion Therap…
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New shot could help tame stubborn Graves' disease
Disease control Recruiting nowThe main purpose of this study is to look at how efgartigimod affects thyroid function in adults with Graves' Disease (GD). The study will also check whether efgartigimod is safe and well tolerated. It will look at how efgartigimod is distributed and eliminated in the body, how i…
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Simple urine test could spot pancreatic cancer early
Diagnosis Recruiting nowThe main purpose of the study is to assess the performance of the Panuri test in detecting pancreatic ductal adenocarcinoma (PDAC) the most common type of pancreatic cancer that accounts for approximately 90% of all pancreatic cancer cases. The study aims to characterize the per…
Sponsor: Urteste S.A • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
New shot could help thyroid patients who Don't respond to usual pills
Disease control Recruiting nowThe main purpose of this study is to look at how efgartigimod affects thyroid function in adults with Graves' Disease (GD). The study will also check whether efgartigimod is safe and well tolerated. It will look at how efgartigimod is distributed and eliminated in the body, how i…
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New monthly shot could help people with obesity shed pounds
Disease control Recruiting nowThe purpose of this clinical study is to learn about the effects and safety of berobenatide (PF-08653944). This may help people with overweight or obesity lose weight. People in this study may also have type 2 diabetes. About 950 adults will be in this study. Berobenatide will b…
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC